{"filing":{"accession_number":"0000724004-26-000056","cik":"0000724004","ticker":"MLAB","company_name":"MESA LABORATORIES INC /CO/","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"mlab20260615_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000056/mlab20260615_8k.htm"},"events":[{"id":11163,"run_id":9785,"accession_number":"0000724004-26-000056","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The disclosure centers on the Board's approval of Lyndsey Crennen's appointment as Chief Accounting Officer, effective upon execution of her Employment Agreement. While the filing includes compensatory details (base salary of $325,000, bonus eligibility of 40%, and long-term incentive awards of $300,000 annually), the principal disclosed action is the appointment itself—a person taking a new executive role. The appointment of a Chief Accounting Officer is material to investors as it affects the company's financial reporting and internal control structure.","company_name":"MESA LABORATORIES INC /CO/","ticker":"MLAB","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":[{"id":7687,"accession_number":"0000724004-26-000056","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on the Board's approval of Lyndsey Crennen's appointment as Chief Accounting Officer, effective upon execution of her Employment Agreement. While the filing includes compensatory details (base salary of $325,000, bonus eligibility of 40%, and long-term incentive awards of $300,000 annually), the principal disclosed action is the appointment itself—a person taking a new executive role. The appointment of a Chief Accounting Officer is material to investors as it affects the company's financial reporting and internal control structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T21:31:06.322398+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7687,"accession_number":"0000724004-26-000056","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on the Board's approval of Lyndsey Crennen's appointment as Chief Accounting Officer, effective upon execution of her Employment Agreement. While the filing includes compensatory details (base salary of $325,000, bonus eligibility of 40%, and long-term incentive awards of $300,000 annually), the principal disclosed action is the appointment itself—a person taking a new executive role. The appointment of a Chief Accounting Officer is material to investors as it affects the company's financial reporting and internal control structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T21:31:06.322398+00:00","company_name":"MESA LABORATORIES INC /CO/","ticker":"MLAB","filing_date":"2026-06-15"}]}